Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,064 Hematology
clinical trials

Multiple Myeloma Clinical Trial
A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Miami VA Medical Center
mi
from
Miami, FL
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Boston University Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Good Samaritan Hospital, Corvallis
mi
from
Corvallis, OR
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Norton Healthcare
mi
from
Louisville, KY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Efficacy and Safety Study of bb2121 Versus Standard Triplet Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)
Status: Enrolling, Phase III
Updated: 12/31/1969
Washington University School of Medicine, Siteman Cancer Center
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hematology Clinical Trial
KRT-232 in Subjects With PMF, Post-PV MF, or Post-ET MF Who Have Failed a JAK Inhibitor
Status: Enrolling, Phase II
Updated: 12/31/1969
University Cancer Institute, LLC
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Hematology Clinical Trial
KRT-232 in Subjects With PMF, Post-PV MF, or Post-ET MF Who Have Failed a JAK Inhibitor
Status: Enrolling, Phase II
Updated: 12/31/1969
Gabrail Cancer Center
mi
from
Canton, OH
Click here to add this to my saved trials
Hematology Clinical Trial
KRT-232 in Subjects With PMF, Post-PV MF, or Post-ET MF Who Have Failed a JAK Inhibitor
Status: Enrolling, Phase II
Updated: 12/31/1969
Innovative Clinical Research Institute, LLC
mi
from
Whittier, CA
Click here to add this to my saved trials
Amyloidogenic Transthyretin (ATTR) Amyloidosis Clinical Trial
A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis
Status: Enrolling, Phase I
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Amyloidogenic Transthyretin (ATTR) Amyloidosis Clinical Trial
A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis
Status: Enrolling, Phase I
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Amyloidogenic Transthyretin (ATTR) Amyloidosis Clinical Trial
A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis
Status: Enrolling, Phase I
Updated: 12/31/1969
Mayo Clinic Minnesota
mi
from
Rochester, MN
Click here to add this to my saved trials
Polycythemia Vera Clinical Trial
KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera
Status: Enrolling, Phase II
Updated: 12/31/1969
University Cancer Institute, LLC
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Polycythemia Vera Clinical Trial
KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera
Status: Enrolling, Phase II
Updated: 12/31/1969
Innovative Clinical Research Institute, LLC
mi
from
Whittier, CA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
An Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple Myeloma
Status: Enrolling, Phase II
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of APVO436 in Patients With AML or MDS
Status: Enrolling, Phase I
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of APVO436 in Patients With AML or MDS
Status: Enrolling, Phase I
Updated: 12/31/1969
The Ohio State University Wexner Medical Center, James Cancer Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Hematology, Ophthalmology, Orthopedics / Podiatry Clinical Trial
Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Research Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Hematology, Ophthalmology, Orthopedics / Podiatry Clinical Trial
Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Research Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
Status: Enrolling, Phase II
Updated: 12/31/1969
Grady Health System
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
Status: Enrolling, Phase II
Updated: 12/31/1969
John B. Amos Cancer Center
mi
from
Columbus, GA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis
Status: Enrolling, Phase II
Updated: 12/31/1969
Central Georgia Cancer Care
mi
from
Macon, GA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Study of Brequinar in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting
Status: Enrolling, Phase II
Updated: 12/31/1969
Providence Portland Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of PTC299 in Relapsed/Refractory Acute Leukemias
Status: Enrolling, Phase I
Updated: 12/31/1969
Gabrail Cancer Center
mi
from
Canton, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of PTC299 in Relapsed/Refractory Acute Leukemias
Status: Enrolling, Phase I
Updated: 12/31/1969
SCRI - Tennessee Oncology
mi
from
Nashville, TN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of PTC299 in Relapsed/Refractory Acute Leukemias
Status: Enrolling, Phase I
Updated: 12/31/1969
Rutgers Cancer Institute of NJ
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers
Status: Enrolling, Phase
Updated: 12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers
Status: Enrolling, Phase
Updated: 12/31/1969
University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Gastroenterology, Hematology, Oncology Clinical Trial
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering at Basking Ridge
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Swedish Cancer Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling, Phase
Updated: 12/31/1969
Norton Healthcare
mi
from
Louisville, KY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling, Phase
Updated: 12/31/1969
St. Peter's University Hospital
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Neurology, Ophthalmology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant Women
Status: Enrolling, Phase
Updated: 12/31/1969
Drexel University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia With Cancer-Related Fatigue
Status: Enrolling, Phase II
Updated: 12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology Clinical Trial
Effects of Nitric Oxide on the Endothelium During Hemolysis.
Status: Enrolling, Phase II
Updated: 12/31/1969
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Chronic Graft-Versus-Host-Disease Clinical Trial
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Chronic Graft-Versus-Host-Disease Clinical Trial
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Chronic Graft-Versus-Host-Disease Clinical Trial
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Chronic Graft-Versus-Host-Disease Clinical Trial
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
Colorado Blood Cancer Institute
mi
from
Denver, CO
Click here to add this to my saved trials
Chronic Graft-Versus-Host-Disease Clinical Trial
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
City of Hope National Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
The Myeloma Pack: A Multi-Modality Educational Intervention Strategy to Engage Patients With Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
University of Colorado Denver Hemophilia & Thrombosis Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
Oklahoma Center for Bleeding and Clotting Disorders
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Iron Overload Due to Repeated Red Blood Cell Transfusions Clinical Trial
Safety and Acceptability of Deferiprone Delayed Release Tablets in Patients With Systemic Iron Overload
Status: Enrolling, Phase II
Updated: 12/31/1969
New York Presbyterian Hospital-Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Immunology / Infectious Diseases Clinical Trial
Evaluation of MyoStrain™ in Clinical Practice
Status: Enrolling, Phase
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KS
Click here to add this to my saved trials
Hematology Clinical Trial
Hydroxyurea Therapy: Optimizing Access in Pediatric Populations Everywhere
Status: Enrolling, Phase II
Updated: 12/31/1969
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Hickman Cancer Center
mi
from
Adrian, MI
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Billings Clinic Cancer Center
mi
from
Billings, MT
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Parkland Health Center-Bonne Terre
mi
from
Bonne Terre, MO
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Saint Francis Medical Center
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Centralia Oncology Clinic
mi
from
Centralia, IL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Western Illinois Cancer Treatment Center
mi
from
Galesburg, IL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Illinois CancerCare - Galesburg
mi
from
Galesburg, IL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Mercy Health Saint Mary's
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Valley Radiation Oncology
mi
from
Peru, IL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Spectrum Health Reed City Hospital
mi
from
Reed City, MI
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Marie Yeager Cancer Center
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Ridgeview Medical Center
mi
from
Waconia, MN
Click here to add this to my saved trials
Chronic Graft Versus Host Disease Clinical Trial
Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig
Status: Enrolling, Phase I
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
64Cu-LLP2A for Imaging Multiple Myeloma
Status: Enrolling, Phase
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Post-Marketing Observational Study of VYXEOS™
Status: Enrolling, Phase
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Recurrent Primary Amyloidosis Clinical Trial
Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapsed Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Wayne State University/Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
An Efficacy and Safety Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KS
Click here to add this to my saved trials
Graft Versus Host Disease Clinical Trial
The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft‑Versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Centennial Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Hematology, Musculoskeletal, Oncology Clinical Trial
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Louis University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM)
Status: Enrolling, Phase II
Updated: 12/31/1969
GSK Investigational Site
mi
from
Madison, WI
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM43239 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Hematology Clinical Trial
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Selinexor in Myelofibrosis Refractory or Intolerant to JAK1/2 Inhibitors
Status: Enrolling, Phase II
Updated: 12/31/1969
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Autoimmune Lymphproliferative Syndrome Clinical Trial
Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Status: Enrolling, Phase
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Neutropenia Clinical Trial
International Registry for Severe Chronic Neutropenia
Status: Enrolling
Updated: 6/23/2005
University of Washington School of Medicine
mi
from
Seattle, WA
Click here to add this to my saved trials
Amyloidosis Clinical Trial
Study of Systemic Amyloidosis Presentation and Prognosis
Status: Enrolling
Updated: 6/23/2005
Indiana University Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Hematology, Musculoskeletal, Oncology Clinical Trial
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation
Status: Enrolling, Phase II
Updated: 9/19/2013
Medical College of Wisconsin Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Hematology Clinical Trial
Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias
Status: Enrolling, Phase I, II
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Hematology Clinical Trial
Diamond Blackfan Anemia Registry (DBAR)
Status: Enrolling, Phase
Updated: 12/31/1969
Cohen Children's Medical Center of NY
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bone Marrow Grafting for Leukemia and Lymphoma
Status: Enrolling, Phase
Updated: 12/31/1969
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
mi
from
Ames, IA
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
mi
from
Athens, GA
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
mi
from
Burlington, VT
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
mi
from
Harrisonburg, VA
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
mi
from
Lebanon, TN
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
mi
from
Madison, WI
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
mi
from
Southfield, MI
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
mi
from
Staten Island, NY
Click here to add this to my saved trials
Childhood Langerhans Cell Histiocytosis Clinical Trial
Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis
Status: Enrolling
Updated: 12/6/2011
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Childhood Langerhans Cell Histiocytosis Clinical Trial
Combination Chemotherapy in Treating Young Patients With Langerhans Cell Histiocytosis
Status: Enrolling
Updated: 12/6/2011
Texas Children's Cancer Center and Hematology Service at Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Antithrombin III Deficiency Clinical Trial
Safety, Pharmacokinetics and Efficacy of an AT-III Concentrate.
Status: Enrolling, Phase II, III
Updated: 2/17/2014
University of Texas Health Science Center
mi
from
Houston, TX
Click here to add this to my saved trials
1 … 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 … 121